eAccess Meetings: 2017 Keystone Symposia on HIV Vaccines

In 2016, The Global HIV Vaccine Enterprise and Keystone Symposia inaugurated a collaboration to produce an ePanel discussion and series of SciTalks presentations that brought together key experts in the HIV prevention vaccine field. The ePanel and SciTalks addressed a broad range of topics pertinent to state-of-the-art HIV vaccine research.

Following the great response to the inaugural video series, the Global HIV Vaccine Enterprise in collaboration with Keystone Symposia is glad to present the second series of eAccess Meetings: 2017 Keystone Symposia on HIV Vaccines.


  • Maria Blasi: “Sequential immunizations with an integrase defective lentiviral vector induce higher magnitude and more durable antibody responses than DNA and protein based vaccine regimens”
  • Gunilla Karlsson Hedestam: “Individualized profiling of germline antibody V genes”
  • Thomas Kepler: “B cell clonal dynamics during sequential immunizations”
  • Elise Landais: “Broadly neutralizing antibodies development: lessons from the Protocol C cohort”
  • Paola Martinez Murillo: “F9, a new class of antibodies that neutralizes autologous tier 2 viruses in NHP immunized with liposome conjugated well-ordered trimers”
  • Thumbi Ndung’u: “Antiretroviral treatment of acute HIV infection and the prospect for a functional cure”
  • Till Schoofs: “Antibody 10-1074 suppresses viremia in HIV-1-infected individuals”

ePanel Discussion: “Antibody Functions Beyond Neutralization”

  • Moderator: Gabriella Scarlatti
  • Panelists: Guido Ferrari, Ann Hessell and Robin Shattock

Date: 7 June 2017
Time: 1:00 PM – 1:55 PM ET

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account